Stay updated on Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3 (from v3.4.2).
    Difference
    0.0%
    Check dated 2026-03-11T14:55:03.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page adds a reference to Primary peritoneal carcinoma and a Genetic and Rare Diseases Information Center resource, and removes the government funding notice. A revision note (v3.4.2) is also shown.
    Difference
    0.2%
    Check dated 2026-02-11T02:20:40.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about funding-related delays was added, and the page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T00:31:24.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated footer/labels to reflect QC status and version (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). Removed older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-27T23:14:54.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.4, replacing the earlier Revision: v3.3.3. No study content, enrollment data, or results are affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T00:47:25.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a comprehensive Locations section listing study sites by state (Alabama through Wisconsin) with revision tag v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T09:19:18.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.